Veeva Systems Inc. (NYSE:VEEV)
Veeva Systems Inc. (NYSE:VEEV) represented a move of -4.65 percent or $4.39 per share and closed its previous day trading session at $85.06. 1.96 Million Shares were traded in the last trading session with an Average Volume of 1.31 Million Shares. The stock currently has a Market Capitalization of 12.54 Billion.
Veeva Systems Inc. operates as a provider of industry-specific, cloud-based software solutions for the life sciences industry. It offers enterprise applications, a multichannel platform, customer relationship management, and content management solutions. The Company provides its solutions to pharmaceutical, animal health, and biotechnology companies. Veeva Systems Inc. is headquartered in Pleasanton, California.
The stock traded between $ 52.17 and $109.05 over 1-Year time period showing its price to sales ratio of 16.37. Veeva Systems Inc. (NYSE:VEEV) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-13.24 and 200-Day Simple Moving Average of $7.3. Its Price to Free Cash Flow is 45.96 and Price to Book of 11.64.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Veeva Systems Inc. (NYSE:VEEV) reported its Actual EPS of $0.39/share. The analysts offering Earnings Estimates for the company were believing that Veeva Systems Inc. could bring EPS of $0.34/share. The difference between Actual EPS and Estimated EPS was 0.05 Percent. Thus showing an Earnings Surprise of 14.7 Percent.
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA)
In the last trading session, Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) added its value by -6.51% closing at the price of $19.67. The stock currently has market capitalization of 1.33 Billion, with average volume of 1.52 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) is showing beta of 1.92. This particular value of beta suggests that Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has historically moved 192% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) is at $-5.71.
The stock currently has RSI of 23.14. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) topped its 52-week high price of $56.70 on 12/21/17 and 52-Week Low Price of $19.38 on 10/24/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 7.53% and monthly volatility of 5.62% respectively.